XML 55 R43.htm IDEA: XBRL DOCUMENT
v3.24.1.u1

NET INCOME ATTRIBUTABLE TO COTY INC. PER COMMON SHARE (Tables) | 9 Months Ended
--- | ---
Mar. 31, 2024
Earnings Per Share [Abstract] |
Schedule of reconciliation of numerators and denominators of basic and diluted EPS computations | Reconciliation between the numerators and denominators of the basic and diluted income per share (“EPS”) computations is presented below:
| Three Months Ended March 31, |  | Nine Months Ended March 31,
| 2024 |  | 2023 |  | 2024 |  | 2023
Amounts attributable to Coty Inc.: |  |  |  |  |  |  |
Net income attributable to Coty Inc. | $ | 3.8 |  |  | $ | 108.4 |  |  | $ | 186.3 |  |  | $ | 475.3 |
Convertible Series B Preferred Stock dividends | (3.3) |  |  | (3.3) |  |  | (9.9) |  |  | (9.9) |
Net income attributable to common stockholders | $ | 0.5 |  |  | $ | 105.1 |  |  | $ | 176.4 |  |  | $ | 465.4 |
Weighted-average common shares outstanding: |  |  |  |  |  |  |
Weighted-average common shares outstanding—Basic | 883.1 |  |  | 851.6 |  |  | 876.7 |  |  | 848.1 |
Effect of dilutive stock options and Series A Preferred Stock (a) | 0.2 |  |  | — |  |  | 0.1 |  |  | — |
Effect of restricted stock and RSUs (b) | 8.7 |  |  | 13.6 |  |  | 9.3 |  |  | 14.0 |
Effect of Convertible Series B Preferred Stock (c) | — |  |  | — |  |  | — |  |  | 23.7 |
Effect of Forward Repurchase Contracts (d) | — |  |  | — |  |  | — |  |  | — |
Weighted-average common shares outstanding—Diluted | 892.0 |  |  | 865.2 |  |  | 886.1 |  |  | 885.8 |
Earnings per common share: |  |  |  |  |  |  |
Earnings per common share - basic | $ | — |  |  | $ | 0.12 |  |  | $ | 0.20 |  |  | $ | 0.55 |
Earnings per common share - diluted (e) | — |  |  | 0.12 |  |  | 0.20 |  |  | 0.54 |
(a) For the three months ended March 31, 2024 and 2023, outstanding stock options and Series A Preferred Stock with purchase or conversion rights to purchase 1.7 million and 5.6 million shares of Common Stock, respectively, were anti-dilutive and excluded from the computation of diluted EPS. For the nine months ended March 31, 2024 and 2023, outstanding stock options and Series A Preferred Stock with purchase or conversion rights to purchase 2.5 million and 5.8 million weighted average shares of Common Stock, respectively, were anti-dilutive and excluded from the computation of diluted EPS. (b) For the three months ended March 31, 2024 and 2023, there were nil anti-dilutive RSUs. For the nine months ended March 31, 2024 and 2023, there were 1.3 million and nil weighted average anti-dilutive RSUs, respectively, excluded from the computation of diluted EPS. (c) For the three months ended March 31, 2024 and 2023 and the nine months ended March 31, 2024 there were 23.7 million dilutive shares of Convertible Series B Preferred Stock excluded from the computation of diluted EPS as their inclusion would be anti-dilutive. (d) For the three and nine months ended March 31, 2024 and 2023, respectively, shares for the Forward Repurchase Contracts were excluded from the computation of diluted EPS as Coty is in the position to receive shares from the counterparties and as such their inclusion would be anti-dilutive. (e) Diluted EPS is adjusted by the effect of dilutive securities, including awards under the Company's equity compensation plans, the convertible Series B Preferred Stock, and the Forward Repurchase Contracts. When calculating any potential dilutive effect of stock options, Series A Preferred Stock, restricted stock, RSUs and PRSUs, the Company uses the treasury method and the if-converted method for the Convertible Series B Preferred Stock and the Forward Repurchase Contracts. The treasury method typically does not adjust the net income attributable to Coty Inc., while the if-converted method requires an adjustment to reverse the impact of the preferred stock dividends of $3.3 and $3.3, respectively, and to reverse the impact of fair market value losses/(gains) for contracts with the option to settle in shares or cash of $7.1 and $(93.9), respectively, if dilutive, for the three months ended March 31, 2024 and 2023 on net income applicable to common stockholders during the period. The if-converted method requires an adjustment to reverse the impact of the preferred stock dividends of $9.9 and $9.9, respectively, and to reverse the impact of fair market value losses/(gains) for contracts with the option to settle in shares or cash of $6.9 and $(100.7), respectively, if dilutive, for the nine months ended March 31, 2024 and 2023 on net income applicable to common stockholders during the period.

X
- References No definition available. + Details
Name: | us-gaap_EarningsPerShareAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 260 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1 + Details
Name: | us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration